Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
    Proceedings
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  Sign up now for:
Become a Member

Veterinary Forum July 2009 (Vol 26, No 7)

Putney develops generic NSAID

    PORTLAND, Maine — Putney, a pharmaceutical company focused on the development of generic drugs for pets, has launched carprofen caplets, a bioequivalent generic version of the canine medication Rimadyl (Pfizer Animal Health) caplets.

    Carprofen is widely used in dogs for the relief of pain and inflammation associated with osteoarthritis, as well as the control of postoperative pain associated with soft tissue and orthopedic surgeries.

    Putney's carprofen caplets have demonstrated bioequivalence to Rimadyl caplets in an FDA-approved study and will be available in 25-mg, 75-mg and 100-mg caplets.

    For more information, visit www.putneyvet.com.

    NEXT: Reader Forum (July 2009)

    didyouknow

    Did you know... Many therapeutic drugs are associated with adverse drug events affecting the hematologic system. These events have been categorized as type A (dose dependent) or type B (idiosyncratic) reactions.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe